TGA approves HRT patch alternatives The ongoing short supply of hormone replacement therapy patches has resulted in the approval of a range of overseas alternatives.
Study urges tailored use of MHT Shared decision-making and an individualised approach are key when it comes to MHT, but there is an ‘urgent need’ for more research.
Puberty blocker pause leaves patients ‘languishing’ GPs caring for young trans people in Queensland will face ‘a very hard time’ following a pause on hormone therapy for under 18s.
Do GPs know enough about this ‘debilitating’ disorder? Experts agree there has been a dire lack of education around PMDD, but GPs could be in the ‘ideal situation’ to help.
TGA renews calls to limit new HRT patch prescriptions The reoccurring shortages are now expected to last until the end of 2025, raising concerns from GPs about how to support their patients long-term.
Tool developed to help GPs manage menopause The MenoPROMPT assessment program has been developed by a team of Australian experts to help GPs better manage menopause.
Improving menopause diagnosis experiences Once taboo, menopause is now at the centre of several guides and toolkits, and experts are calling on GPs to read up on best practice treatment.
Lack of safety data prompts guidance on oestrogen therapy A summary of evidence is out for prescribing oestrogen treatments for the estimated 75% of breast cancer patients who develop genitourinary symptoms.
Feminist language being hijacked to market medical tests Narratives around empowerment and women’s rights are being co-opted to market interventions not backed by evidence, according to new research.
Consider MHT for bones: New menopause guideline Almost a decade in the making, a toolkit refresh is the first to include advice on prescribing hormone therapy specifically for bone health.